On Friday, July 24, President Donald Trump signed four Executive Orders designed to lower the cost of prescription drugs. This alert will focus on three
On April 2, the Food and Drug Administration (FDA) announced that, effective immediately, it is modifying its current policy to shorten the abstinence period, from
The Centers for Medicare & Medicaid Services (CMS) released a toolkit on Medicare payments to providers of telehealth and telemedicine services on Friday, March 20.
HRSA/OPA Guidance in Response to COVID-19
Late yesterday, HRSA/OPA updated its website to include guidance addressing the COVID-19 pandemic. The guidance states:
Case-by-Case Waivers –
The COVID-19 pandemic has created an increased need for the use of telehealth services. Powers has received several questions from Ryan White clinics about whether
On January 28, 2020, HRSA posted results
of its 340B Program audit of four pharmaceutical manufacturers in fiscal year 2019. Three of the four
audited manufacturers were
On January
27, 2020, the U.S. Government Accountability Office (GAO) released a report (the Report) assessing oversight
by the Department of Health and Human Services (HHS) of
On January 17, 2020, the Medicare Payment Advisory
Commission (MedPAC) held its first meeting of the year, including a session
discussing a report requested by the House
On January
10, 2020, the U.S. Government Accountability Office (GAO) released a report
(the Report) analyzing HRSA’s oversight of 340B eligibility requirements for
nongovernmental hospitals. The Report concludes
HRSA announced that it has awarded Apexus LLC the prime vendor contract again after a competitive bid process. Apexus has been the 340B Prime Vendor
